Search for: "BRISTOL-MYERS SQUIBB" Results 461 - 480 of 863
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Nov 2008, 12:07 pm
In the white collar arena, his term will be remembered for, among other things, the deferred-prosecution agreement with Bristol-Myers Squibb (though the securities fraud prosecutions of two former executives haven’t exactly gone according to plan), and his office’s prosecution of former executives involved in accounting fraud at Cendant Corp. [read post]
9 Aug 2010, 3:07 pm
--Collazo v Bristol-Myers Squibb Manufacturing, Inc, (1st Circuit): An interesting one here. [read post]
9 Nov 2006, 9:08 pm
District Court for the Northern District of Illinois relied on Bristol-Myers Squibb v. [read post]
22 May 2024, 4:09 am by Dennis Crouch
Henry Hadad – Senior VP & Deputy General Counsel of Innovation Law at Bristol Myers Squibb, leading IP efforts. [read post]
17 Jul 2008, 12:11 am
Bristol-Myers Squibb is starting to send out the $500 million refunds to the state governments it ripped off. [read post]
24 Jan 2017, 3:29 am by Walter Olson
Quinn line of cases] High court will hear new cases on limits of personal jurisdiction [Bristol-Myers Squibb v. [read post]
3 Oct 2022, 5:45 am by Lawrence Solum
Twice in the new era – with Bristol-Myers Squibb (BMS) in 2017 and in the Ford Motor Company (Ford) in 2021 -- the Court has addressed the connection required between the defendant's contact with the forum and harm suffered by the plaintiff. [read post]
26 Jul 2011, 3:25 am by Bob Kraft
” Medscape reported, “Across the companies’ [Bristol-Myers Squibb and AstraZeneca] 11 clinical trials, there have been nine bladder cancers in 5,478 patients on the drug compared with one case in 3,156 controls; and there have also been nine cases of breast cancer in 2,223 women on the drug compared with just one in 1,053 female controls. [read post]
9 Jun 2009, 9:05 am
Bodnar, a former senior vice president at Bristol-Myers Squibb, had pleaded guilty to making a false statement to the federal government about the company's efforts to resolve a patent dispute over the blood thinner Plavix. [read post]
28 Oct 2011, 4:35 pm
Although the "patent cliff" is bad news for major pharmaceutical manufacturers such as AstraZeneca, Pfizer, and Bristol-Myers Squibb/Sanofi Pharmaceuticals, many patients will finally be able afford the prescriptions they need to manage their conditions. [read post]
24 Oct 2006, 2:33 pm
In late April 2006 Bristol-Myers Squibb announced that it would no longer sell Tequin. [read post]
30 Jan 2019, 5:44 am
M&A being lumpy and unpredictable as ever, 2019 has opened with a number of notable deals, not least the sale of Celgene to Bristol-Myers Squibb for $95 billion, somewhat defying gloomy predictions for the year. [read post]
3 Dec 2009, 10:16 pm
Supporters can click the Make it Happen link and send an email to the CEOs of Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer Inc. and Sequoia Pharmaceuticals Inc. [read post]
5 Mar 2019, 9:38 am by Patrick A. Malone
Media reports of the Senate Finance hearing called it “political theater,” and it offered lawmakers a chance to vent at execs from AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck, Pfizer, and Sanofi. [read post]
19 Dec 2011, 9:30 am
Last week, the JPML denied a motion by Bristol-Myers Squibb and Sanofi-Aventis to centralize the federal Plavix litigation in the U.S. [read post]
4 Apr 2022, 5:29 am by Bob Ambrogi
He has also worked at Booz Allen Hamilton and Bristol Myers-Squibb. [read post]
15 Aug 2017, 4:02 am by Edith Roberts
” In an op-ed at STAT, Michael Burg weighs in on the court’s recent opinion in Bristol-Myers Squibb Co. v. [read post]
23 Jan 2014, 6:45 pm by Dr. Shezad Malik
A number of similar cases have also filed against AstraZeneca and Bristol-Myers Squibb, involving plaintiffs diagnosed with pancreatic cancer from Onglyzer, another incretin mimetic drug that is not currently joined with the MDL. [read post]
30 Jun 2012, 9:12 am by Cal Warriner
Late Friday, June 29, Bristol-Myers Squibb announced it was buying the pharmaceutical company and paying off some debt to Eli Lilly & Co for a reported deal worth $7 billion. [read post]